Skip to main content
James Hobson

Dr James Hobson
BSc (Hons) MSc MRes PhD

Contact

J.Hobson@liverpool.ac.uk

+44 (0)151 795 1377

Research

Nanoengineering of Nucleoside Reverse Transcriptase Inhibitors (NRTI) Sustained Release Formulations

National Institutes of Health (NIH) funded project. Collaborating with Department of Pharmacology at University of Liverpool and Division of Clinical Pharmacology at Johns Hopkins University (USA).

Polymer Stabilised Nanoemulsions for Drug Delivery

Developing nanoemulsion based delivery systems specifically designed to improve the delivery of poorly water soluble drugs. The main focus of the project is on Antiretroviral drugs for the treatment of HIV/AIDS.

Centre of Excellence in Long-Acting Therapeutics (CELT)

The Centre of Excellence in Long-acting Therapeutics (CELT) is a cross-faculty research initiative combining our world leading expertise in pharmacology and materials chemistry and working with international partners to disseminate research findings in long-acting medicine and change the global landscape of drug administration

Research groups

  • Rannard Group

Research grants

In vitro and in vivo assessment of nanoemulsion co-formulations of dolutegravir and rilpivirine.

BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)

June 2017 - December 2018